Skip to main content
Midas Edge

My Size, Inc.

For the period ended Sep 30, 2025. Filed Nov 14, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 14, 2025

MYSZ$0.69-5.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Condensed Consolidated Interim Statements of Changes in Stockholders’ Equity

Condensed Consolidated Interim Statements of Changes in Stockholders’ Equity (Unaudited)

Common stock · Additional paid-in · Accumulated other comprehensive · Accumulated · Total stockholders’
NumberAmountcapitallossdeficitequity
Balance as of January 1, 20252,040,159271,608(825)(63,876)6,909
Stock-based compensation related to options granted to employees and consultants10,000-*84--84
Issuance of shares pursuant to At The Market Offering Agreement for - net of $252 issuance cost**1,557,72722,844--2,846
Investment in Shoe Size Me ***241,093-*338--338
Total comprehensive loss--(36)(2,845)(2,881)
Balance as of September 30, 20253,848,979474,874(861)(66,721)7,296
(*)Represents an amount less than $1.
(**)See note 9
(***)See note 6
Common stock · Additional paid-in · Accumulated other comprehensive · Accumulated · Total stockholders’
NumberAmountcapitallossdeficitequity
Balance as of January 1, 2024452,724165,386(771)(59,881)4,735
Stock-based compensation related to options granted to employees and consultants80,000-*306--306
Issuance of shares post Business Combination4,360-*3--3
Effect of reverse stock split74,683-*----
Issuance of shares, net of issuance cost of $44279,000-*2,819--2,819
Exercise of shares in abeyance478,364-*----
Total comprehensive loss---(125)(3,280)(3,405)
Balance as of September 30, 20241,169,131168,514(896)(63,161)4,458
(*)Represents an amount less than $1.
Common stock · Additional paid-in · Accumulated other comprehensive · Accumulated · Total stockholders’
NumberAmountcapitallossdeficitequity
Balance as of July 1, 20253,103,076373,662(865)(65,386)7,414
Stock-based compensation related to options granted to employees and consultants--16--16
Issuance of shares pursuant to At The Market Offering Agreement for - net of $37 issuance cost**504,8101858--859
Investment Shoe Size Me241,093-*338--338
Total comprehensive loss---4(1,335)(1,331)
Balance as of September 30, 20253,848,979474,874(861)(66,721)7,296
(*)Represents an amount less than $1.
(**)See note 9
(***)See note 6
Common stock · Additional paid-in · Accumulated other comprehensive · Accumulated · Total stockholders’
NumberAmountcapitallossdeficitequity
Balance as of July 1, 2024883,131168,425(870)(61,861)5,695
Stock-based compensation related to options granted to employees and consultants--89--89
Exercise of shares in abeyance286,000-*----
Total comprehensive loss---(26)(1,300)(1,326)
Balance as of September 30, 20241,169,131168,514(896)(63,161)4,458
(*)Represents an amount less than $1.
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.